These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23254249)
1. Safety of macrolides during pregnancy. Lin KJ; Mitchell AA; Yau WP; Louik C; Hernández-Díaz S Am J Obstet Gynecol; 2013 Mar; 208(3):221.e1-8. PubMed ID: 23254249 [TBL] [Abstract][Full Text] [Related]
2. Use of macrolides during pregnancy and the risk of birth defects: a population-based study. Bérard A; Sheehy O; Zhao JP; Nordeng H Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1241-8. PubMed ID: 26513406 [TBL] [Abstract][Full Text] [Related]
3. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Cooper WO; Ray WA; Griffin MR Obstet Gynecol; 2002 Jul; 100(1):101-6. PubMed ID: 12100810 [TBL] [Abstract][Full Text] [Related]
4. Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: A European case-control study. Leke AZ; Dolk H; Loane M; Casson K; Nelen V; Barišić I; Garne E; Rissman A; O'Mahony M; Neville AJ; Pierini A; Bergman JEH; Klungsøyr K; Materna-Kiryluk A; Bielenska AL; Carbonell CC; Addor MC; Tucker D Reprod Toxicol; 2021 Mar; 100():101-108. PubMed ID: 33454317 [TBL] [Abstract][Full Text] [Related]
6. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study. Fan H; Gilbert R; O'Callaghan F; Li L BMJ; 2020 Feb; 368():m331. PubMed ID: 32075790 [TBL] [Abstract][Full Text] [Related]
7. Pregnancy outcomes following maternal macrolide use: A systematic review and meta-analysis. Keskin-Arslan E; Erol H; Uysal N; Karadas B; Temiz T; Kaplan YC Reprod Toxicol; 2023 Jan; 115():124-146. PubMed ID: 36549458 [TBL] [Abstract][Full Text] [Related]
8. Pregnancy outcome after gestational exposure to erythromycin - a population-based register study from Norway. Romøren M; Lindbæk M; Nordeng H Br J Clin Pharmacol; 2012 Dec; 74(6):1053-62. PubMed ID: 22463376 [TBL] [Abstract][Full Text] [Related]
9. The safety of macrolides during lactation. Goldstein LH; Berlin M; Tsur L; Bortnik O; Binyamini L; Berkovitch M Breastfeed Med; 2009 Dec; 4(4):197-200. PubMed ID: 19366316 [TBL] [Abstract][Full Text] [Related]
10. Macrolide antibiotics for bronchiectasis. Kelly C; Chalmers JD; Crossingham I; Relph N; Felix LM; Evans DJ; Milan SJ; Spencer S Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012406. PubMed ID: 29543980 [TBL] [Abstract][Full Text] [Related]
11. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Abdellatif M; Ghozy S; Kamel MG; Elawady SS; Ghorab MME; Attia AW; Le Huyen TT; Duy DTV; Hirayama K; Huy NT Eur J Pediatr; 2019 Mar; 178(3):301-314. PubMed ID: 30470884 [TBL] [Abstract][Full Text] [Related]
12. Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides. Gorelik E; Masarwa R; Perlman A; Rotshild V; Muszkat M; Matok I Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29610207 [TBL] [Abstract][Full Text] [Related]
13. Erythromycin use during pregnancy in relation to pyloric stenosis. Louik C; Werler MM; Mitchell AA Am J Obstet Gynecol; 2002 Feb; 186(2):288-90. PubMed ID: 11854652 [TBL] [Abstract][Full Text] [Related]
14. The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers. Wright AJ; Gomes T; Mamdani MM; Horn JR; Juurlink DN CMAJ; 2011 Feb; 183(3):303-7. PubMed ID: 21242274 [TBL] [Abstract][Full Text] [Related]
15. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Hauben M; Amsden GW Drug Saf; 2002; 25(13):929-42. PubMed ID: 12381214 [TBL] [Abstract][Full Text] [Related]
16. The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study. Bar-Oz B; Weber-Schoendorfer C; Berlin M; Clementi M; Di Gianantonio E; de Vries L; De Santis M; Merlob P; Stahl B; Eleftheriou G; Maňáková E; Hubičková-Heringová L; Youngster I; Berkovitch M Drug Saf; 2012 Jul; 35(7):589-98. PubMed ID: 22702640 [TBL] [Abstract][Full Text] [Related]
17. Macrolide antibiotics and the risk of ventricular arrhythmia in older adults. Trac MH; McArthur E; Jandoc R; Dixon SN; Nash DM; Hackam DG; Garg AX CMAJ; 2016 Apr; 188(7):E120-E129. PubMed ID: 26903359 [TBL] [Abstract][Full Text] [Related]
18. Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study. Quinn KL; Macdonald EM; Gomes T; Mamdani MM; Huang A; Juurlink DN; Drug Saf; 2017 Sep; 40(9):835-840. PubMed ID: 28421551 [TBL] [Abstract][Full Text] [Related]
19. Association between maternal exposure to housing renovation and offspring with congenital heart disease: a multi-hospital case-control study. Liu Z; Li X; Li N; Li S; Deng K; Lin Y; Chen X; You F; Li J; Mu D; Wang Y; Zhu J Environ Health; 2013 Mar; 12():25. PubMed ID: 23522351 [TBL] [Abstract][Full Text] [Related]
20. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. Principi N; Esposito S Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]